1. Most Discussed
  2. Gainers & Losers

Geneuro announces first patient treated in phase 2A study with GNBAC1 in type 1 diabetes

Bookmark and Share
  1. June 19 (Reuters) - GENEURO SA GNRO.PA :

    • ANNOUNCES FIRST PATIENT TREATED IN PHASE 2A STUDY WITH GNBAC1 IN TYPE 1 DIABETES
    • AUSTRALIAN PHASE 2A CLINICAL STUDY PLANS TO ENROLL 60 ADULT PATIENTS IN OVER 10 CENTERS
    • LAST PATIENT ENROLMENT IS EXPECTED BY END 2017


DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

To read reuters' full disclaimer click here
Top